BE's pediatric pneumonia jab gets CDSCO expert panel approval
The BE's pneumococcal conjugate vaccine (PCV) can be administered to infants at 6, 10 and 14 weeks of age. Streptococcus pneumoniae infection continues to be a leading cause of child mortality under 5 years of age in India and in developing countries.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Children | India Health | Meningitis Vaccine | Pediatrics | Pharmaceuticals | Pneomococcal Vaccine | Pneumonia | Vaccines